A simple, sensitive and highly selective electrochemical method was developed for the simultaneous determination of nitazoxanide and ofloxacin in aqueous media (Britton-Robinson buffer, pH-8.36) on a hanging mercury drop electrode (HMDE) using differential pulse polarography (DPP). Using DPP a separation of about 936 mV between the peak oxidation potentials of nitazoxanide and ofloxacin present in binary mixtures was obtained. The quantification limits for the simultaneous determination of nitazoxanide and ofloxacin were 0.083 μg/ml and 0.208 μg/ml, respectively. The proposed method was successfully applied for the simultaneous determination of nitazoxanide and ofloxacin in bulk drug and pharmaceutical tablet formulation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425074 | PMC |
| http://dx.doi.org/10.4103/0250-474X.99022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Second-line Therapy for Helicobacter Pylori Eradication: State of the Art.
Mini Rev Med Chem
September 2022
Section of Gastroenterology, Department of Emergency and Organ Transplantation, University "Aldo Moro" of Bari, 70124 Bari, Italy.
Helicobacter pylori (H. pylori) is a Gram negative spiraliform bacterium that colonizes the human stomach. It is the most common cause of chronic gastritis, peptic ulcer, and gastric carcinoma.
View Article and Find Full Text PDFEfficacy of levofloxacin, omeprazole, nitazoxanide, and doxycycline (LOAD) regimen compared with standard triple therapy to eradicate infection: a prospective randomized study from a tertiary hospital in India.
Gastroenterol Hepatol Bed Bench
January 2021
Department of Radiology, SKIMS, Soura, India.
Aim: In this study, the efficacy of 14-day triple therapy was compared with that of a novel ten-day LOAD regimen to eradicate infection in India.
Background: infection is widespread in India. Resistance to antibiotics commonly used against is increasing rapidly, leading to traditional triple therapy's lower success.
Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study.
Helicobacter
October 2021
Centre for Digestive Diseases, Five Dock, NSW, Australia.
Background: Vonoprazan fumarate is a novel potassium-competitive acid blocker more effective in suppressing acid production than proton pump inhibitors (PPIs) and when combined with antibiotics has been used to eradicate Helicobacter pylori (H. pylori) infection. However, it has not yet been examined in an Australian setting.
View Article and Find Full Text PDFComparison between Hybrid, Reverse Hybrid, and Non-Bismuth Levofloxacin Quadruple Regimens for Infection in Egypt: A Randomized Trial.
Middle East J Dig Dis
July 2021
Lecturer of Internal Medicine, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt.
BACKGROUND The prevalence of Helicobacter pylori () in developing countries is 50.8%, with the highest occurrence presented in Africa (79.1%).
View Article and Find Full Text PDFEvolution of COVID-19 Pregnancies Treated With Nitazoxanide in a Third-Level Hospital.
Cureus
May 2021
Faculty of Medicine, Autonomous University of the State of Mexico, Toluca, MEX.
Background Nitazoxanide shows adequate activity against coronavirus. The aim of this study was to describe the behavior of coronavirus disease 2019 (COVID-19) in pregnant women treated with nitazoxanide. Methodology This cross-sectional study included the files of COVID-19 positive pregnant women treated with nitazoxanide 500 mg every 6 hours, levofloxacin every 12 hours, and clarithromycin 500 mg every 12 hours.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!